Testing the Glasgow-Blatchford bleeding score in Tunisian adults with upper gastrointestinal bleeding
Official title: External Validation of the Glasgow-Blatchford Bleeding Score in a Tunisian Population
Run by Hôpital Universitaire Sahloul · NCT07089277 · Data updated 2026-11-12
This project will see if the Glasgow‑Blatchford Score can predict 30‑day complications in adults in Tunisia who come to the emergency department with non‑traumatic upper gastrointestinal bleeding.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | Hôpital Universitaire Sahloul Academic / other |
| Locations | 1 site (Sousse) |
| Status | Recruiting |
| Started | January 1, 2024 |
| Main results expected | December 30, 2025 |
| Study ends | December 30, 2025 |
| Registry record updated | July 28, 2025 |
| Trial ID | NCT07089277 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) presenting to participating Tunisian emergency departments with non‑traumatic upper gastrointestinal bleeding who consent and have complete follow‑up data.
✕Probably not a fit
Patients under 18, those with traumatic or non‑upper GI bleeding (for example isolated hemorrhoidal bleeding), or those who do not consent or are lost to follow‑up are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter observational study will enroll adults (≥18 years) presenting with non‑traumatic upper gastrointestinal bleeding to participating emergency departments, with clinical and epidemiological data collected using a standardized form. Investigators will calculate each patient's Glasgow‑Blatchford Score at presentation and follow patients for 30 days to record outcomes including rebleeding, need for hemostatic intervention, complications, and mortality. Statistical analysis will measure the score's predictive performance using sensitivity, specificity, and predictive values for 30‑day outcomes. The goal is to determine whether the GBS can reliably stratify risk in the Tunisian setting where routine hospitalization of all patients is common.
Why it matters
Potential benefit: If successful, the GBS could help clinicians identify low‑risk patients who may avoid unnecessary hospitalization and allow resources to be focused on higher‑risk individuals.
How similar studies have gone: The Glasgow‑Blatchford Score has demonstrated predictive utility in multiple international cohorts, although validation data specific to Tunisia are limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (≥18 years) presenting with non-traumatic upper gastrointestinal bleeding Exclusion Criteria: * patients under 18 years of age. Diagnosis of external hemorrhoids with mucosal lesions. Patients who do not consent, are lost to follow-up, or have incomplete data.
Where it's running
-
Sahloul University Hospital
Sousse, Tunisia Recruiting
Study contacts
- Study coordinator: Riadh Boukef, Professor
- Email: boukef.riadh@famso.u-sousse.tn
- Phone: +21698676745
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Tranexamic Acid and Vitamin K to Treat Upper Gastrointestinal Bleeding in Cirrhotic Patients
This study is testing whether giving Tranexamic acid and vitamin K can help control bleeding in the stomach for people with liver cirrhosis.
-
Using PuraStat® with Adrenaline for treating upper gastrointestinal bleeding
This study is testing if using a special gel called PuraStat® with Adrenaline can help people with upper gastrointestinal bleeding do better than the usual treatment.
-
Comparing OTSC and Angiographic Embolization for Severe Upper Gastrointestinal Bleeding
This study is testing whether a new clip treatment can work as well as a traditional procedure for stopping severe bleeding in the stomach and intestines for patients with certain types of bleeding.
-
Carbon footprint of diagnostic versus therapeutic upper GI endoscopy
This project will measure how much carbon is produced by diagnostic endoscopy for dyspepsia compared with therapeutic endoscopy for non-variceal upper GI bleeding.
-
Predicting rebleeding risk in patients with acute gastrointestinal bleeding
This study is trying to create a better way to predict which patients who have had serious stomach bleeding are at risk of bleeding again, so doctors can provide better care and prevention.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.